Recce Receives 'First Strike' Against Remuneration Report; Shares Up 3%
MT Newswires Live2025-11-05
Recce Pharmaceuticals (ASX:RCE) received its "first strike" against its remuneration report during its annual general meeting on Wednesday.
Of the total number of votes cast, over 19% of the votes were in favor of the executive pay report, while nearly 81% were against it, a same-day filing with the Australian bourse showed.
More than 25% of shareholders' votes cast against a remuneration report resolution makes a "strike," according to the Corporations Act of 2001.
Shares of the company were up nearly 3% in recent Wednesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
